why choose us

First received: November 15, 2022

Clinical Trial: Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Neuroendocrine Tumors

Study Type: INTERVENTIONAL


Official Title: A Phase I/IIa First-in-Human Study of [212Pb]VMT-?-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors

Brief Summary: This study is Phase I/IIa First-in-Human Study of [212Pb]VMT-?-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors

Read more